United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1. progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2. undiagnosed abnormal genital bleeding. 3. known, suspected, or history of breast cancer. 4. active deep vein thrombosis, pulmonary embolism or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6. known liver dysfunction or disease. 7. known or suspected pregnancy.

Canada - English - Health Canada

pharmascience inc - progesterone - capsule - 200mg - progesterone 200mg - progestins

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - progesterone 200mg;  ; progesterone 200mg; progesterone 200mg - capsule - 200 mg - active: progesterone 200mg   excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 200mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 200mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide - oral route: hormone replacement therapy - adjunctive use with an oestrogen in postmenopausal women with an intact uterus (for hormone replacement therapy [hrt]). vaginal route: luteal phase support - supplementation of the luteal phase during assisted reproductive technology (art) cycles.

United States - English - NLM (National Library of Medicine)

avkare, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: - progesterone capsules should not be used in patients with known hypersensitivity to itsingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. - undiagnosed abnormal genital bleeding. - known, suspected, or history of breast cancer. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. - known liver dysfunction or disease. - known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: - progesterone capsules should not be used in patients with known hypersensitivity to itsingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. - undiagnosed abnormal genital bleeding. - known, suspected, or history of breast cancer. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. - known liver dysfunction or disease. - known or suspected pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - progesterone, quantity: 200 mg - pessary, moulded - excipient ingredients: hard fat - oripro pessaries are indicated for:,1. assisted reproductive technology (art) treatment of infertile women with progesterone deficiency, requiring progesterone supplementation or replacement to support embryo implantation and maintain initial pregnancy.,2. prevention of preterm birth in singleton pregnancies at risk due to:,- shortened cervix (midtrimester sonographic cervix less than or equal to 25 mm). and/or,- where there is a history of spontaneous preterm birth.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - progesterone, quantity: 200 mg - pessary, moulded - excipient ingredients: hard fat - oripro pessaries are indicated for:,1. assisted reproductive technology (art) treatment of infertile women with progesterone deficiency, requiring progesterone supplementation or replacement to support embryo implantation and maintain initial pregnancy.,2. prevention of preterm birth in singleton pregnancies at risk due to:,- shortened cervix (midtrimester sonographic cervix less than or equal to 25 mm). and/or,- where there is a history of spontaneous preterm birth.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: - progesterone capsules should not be used in patients with known hypersensitivity to itsingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. - undiagnosed abnormal genital bleeding. - known, suspected, or history of breast cancer. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. - known liver dysfunction or disease. - known or suspected pregnancy.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

besins healthcare sa-nv - progesterone 200 mg - capsule, soft - 200 mg - progesterone 200 mg - progesterone

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1. progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2. undiagnosed abnormal genital bleeding. 3. known, suspected, or history of breast cancer. 4. active deep vein thrombosis, pulmonary embolism or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6. known liver dysfunction or disease. 7. known or suspected pregnancy.